{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:23:41Z","timestamp":1778088221383,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00415-020-09709-3","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T17:03:02Z","timestamp":1579712582000},"page":"1353-1357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The outcome of acute functional neurological disorder: a meta-analysis of stroke-mimic presentations"],"prefix":"10.1007","volume":"267","author":[{"given":"Suhas","family":"Simhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Tsivgoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristeidis","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei V.","family":"Alexandrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0992-1917","authenticated-orcid":false,"given":"Richard A.","family":"Kanaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"9709_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.annemergmed.2011.09.011","volume":"59","author":"V Artto","year":"2012","unstructured":"Artto V, Putaala J, Strbian D, Meretoja A, Piironen K, Liebkind R, Silvennoinen H, Atula S, Happola O, Helsinki Stroke Thrombolysis Registry G (2012) Stroke mimics and intravenous thrombolysis. Ann Emerg Med 59:27\u201332","journal-title":"Ann Emerg Med"},{"key":"9709_CR2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","volume":"38","author":"JL Banks","year":"2007","unstructured":"Banks JL, Marotta CA (2007) Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 38:1091\u20131096","journal-title":"Stroke"},{"key":"9709_CR3","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.10.019","volume":"22","author":"AM Brunser","year":"2013","unstructured":"Brunser AM, Illanes S, Lavados PM, Munoz P, Carcamo D, Hoppe A, Olavarria VV, Delgado I, Diaz V (2013) Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study. J Stroke Cerebrovasc Dis 22:1140\u20131145","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9709_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1468-1331.2011.03367.x","volume":"18","author":"Y Chen","year":"2011","unstructured":"Chen Y, Bogosavljevic V, Leys D, Jovanovic D, Beslac-Bumbasirevic L, Lucas C (2011) Intravenous thrombolytic therapy in patients with stroke mimics: baseline characteristics and safety profile. Eur J Neurol 18:1246\u20131250","journal-title":"Eur J Neurol"},{"key":"9709_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.yebeh.2010.10.022","volume":"20","author":"R Duncan","year":"2011","unstructured":"Duncan R, Razvi S, Mulhern S (2011) Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic. Epilepsy Behav 20:308\u2013311","journal-title":"Epilepsy Behav"},{"key":"9709_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00415-011-6354-9","volume":"259","author":"A Forster","year":"2012","unstructured":"Forster A, Griebe M, Wolf ME, Szabo K, Hennerici MG, Kern R (2012) How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol 259:1347\u20131353","journal-title":"J Neurol"},{"key":"9709_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/jnnp-2015-311114","volume":"88","author":"S Gargalas","year":"2017","unstructured":"Gargalas S, Weeks R, Khan-Bourne N, Shotbolt P, Simblett S, Ashraf L, Doyle C, Bancroft V, David AS (2017) Incidence and outcome of functional stroke mimics admitted to a hyperacute stroke unit. J Neurol Neurosurg Psychiatry 88:2\u20136","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9709_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/jnnp-2013-305321","volume":"85","author":"J Gelauff","year":"2014","unstructured":"Gelauff J, Stone J, Edwards M, Carson A (2014) The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry 85:220\u2013226","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9709_CR9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"9709_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","volume":"172","author":"JPT Higgins","year":"2009","unstructured":"Higgins JPT, Thompson SG, Spiegelhalter DJ (2009) A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A (Statistics in Society) 172:137\u2013159","journal-title":"J R Stat Soc Ser A (Statistics in Society)"},{"key":"9709_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.048","volume":"24","author":"C Lewandowski","year":"2015","unstructured":"Lewandowski C, Mays-Wilson K, Miller J, Penstone P, Miller DJ, Bakoulas K, Mitsias P (2015) Safety and outcomes in stroke mimics after intravenous tissue plasminogen activator administration: a single-center experience. J Stroke Cerebrovasc Dis 24:48\u201352","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9709_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1037\/1082-989X.7.1.105","volume":"7","author":"SB Morris","year":"2002","unstructured":"Morris SB, DeShon RP (2002) Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods 7:105\u2013125","journal-title":"Psychol Methods"},{"key":"9709_CR13","unstructured":"Nicholson TR, Carson A, Edwards MJ, Goldstein LH, Hallett M, Mildon B, Nielsen G, Nicholson C, Perez DL, Pick S, Stone J, and the FNDCOMG, follows F-Cgcaa (2019) Outcome measures for functional neurological disorder: a review of the theoretical complexities. J Neuropsychiatry Clin Neurosci:appineuropsych19060128"},{"key":"9709_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000337677","volume":"68","author":"H Sarikaya","year":"2012","unstructured":"Sarikaya H, Yilmaz M, Luft AR, Gantenbein AR (2012) Different pattern of clinical deficits in stroke mimics treated with intravenous thrombolysis. Eur Neurol 68:344\u2013349","journal-title":"Eur Neurol"},{"key":"9709_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0196-0644(03)00443-8","volume":"42","author":"PA Scott","year":"2003","unstructured":"Scott PA, Silbergleit R (2003) Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann Emerg Med 42:611\u2013618","journal-title":"Ann Emerg Med"},{"key":"9709_CR16","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1161\/STROKEAHA.110.609339","volume":"42","author":"G Tsivgoulis","year":"2011","unstructured":"Tsivgoulis G, Alexandrov AV, Chang J, Sharma VK, Hoover SL, Lao AY, Liu W, Stamboulis E, Alexandrov AW, Malkoff MD, Frey JL (2011) Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke 42:1771\u20131774","journal-title":"Stroke"},{"key":"9709_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/01.STR.0000157596.13234.95","volume":"36","author":"JT Wilson","year":"2005","unstructured":"Wilson JT, Hareendran A, Hendry A, Potter J, Bone I, Muir KW (2005) Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview. Stroke 36:777\u2013781","journal-title":"Stroke"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-020-09709-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:21:30Z","timestamp":1611188490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-020-09709-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["9709"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09709-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"24 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"V. T. has received travel support and honoraria for participation in advisory boards and speaker fees from Boehringer Ingelheim, the manufacturer of alteplase. The other authors report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Participants gave written, informed consent as per their contributing studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}}]}}